CardioComm Solutions to begin immediate rollout of GEMS™ for Windows 7 remote ECG analysis, data management software to extensive base of current US health care providers and customers.
TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has granted an aggregate of 500,060 incentive stock options. 250,060 options have been granted to Mr. Etienne Grima, the Company’s Chief Executive Officer, and 250,000 options have been granted to a contractor of the Company. The 500,060 options issued are exercisable at $0.144 per share for five years from the date of grant, vest equally over 18 months at the end of each three month period from the date of grant and are subject to a four month hold period. The grant of options is subject to the provisions of the Company’s Omnibus Share Compensation Plan, the policies of the TSX Venture Exchange and applicable securities laws.
The Company also announced that it intends to issue an aggregate of 79,693 common shares of the Company to Simi Grosman, a director of the Company. The shares will be issued at a deemed price of $0.10 per share, for a total value of $8,000, for services rendered to the Company in the months of January, February and March of 2014 pursuant to a services agreement previously disclosed by the Company on March 8, 2013. The shares will be issued at a 5% premium to the closing price of the Company’s shares at the end of each month in which services were provided. The issuance of shares is subject to approval by the TSX Venture Exchange.
